<DOC>
	<DOCNO>NCT01620437</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial investigate bioequivalence two formulation biphasic insulin aspart 50 ( NN-X14Mix50 ) healthy Japanese subject .</brief_summary>
	<brief_title>Bioequivalence Two Formulations Biphasic Insulin Aspart 50 Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>BMI ( body mass index ) 1929 kg/m^2 ( inclusive ) Fasting blood glucose 3.86.0 mmol/L ( inclusive ) Nonsmokers Subjects firstdegree relative diabetes mellitus Subjects smoke 5 cigarette per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>